| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.26B | +0.6% |
| Cost of Revenue | $2.24B | +2.8% |
| Gross Profit | $1.02B | -3.9% |
| R&D Expense | $96.7M | -2.0% |
| SG&A Expense | $812.1M | +11.6% |
| Operating Income | $203.5M | -38.2% |
| Pre-tax Income | $111.7M | -50.3% |
| Income Tax | $28.1M | -48.1% |
| Net Income | $81.9M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $435.0M | +8.9% |
| Inventory | $367.2M | +5.9% |
| Current Assets | $1.40B | -1.5% |
| Total Assets | $6.03B | +3.7% |
| Current Liabilities | $846.3M | +11.9% |
| Long-term Debt | $1.92B | -7.0% |
| Stockholders' Equity | $2.37B | +2.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $301.6M | +17.4% |
| Capital Expenditures | $106.6M | -12.6% |
| Investing Cash Flow | -$97.0M | +19.6% |
| Financing Cash Flow | -$257.1M | -112.7% |
| Free Cash Flow | $195.0M | +44.6% |
| -51.7% |
| EPS (Basic) | $0.90 | -51.6% |
| EPS (Diluted) | $0.89 | -51.6% |